Correlation Between Monopar Therapeutics and Avax Techs
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Avax Techs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Avax Techs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and Avax Techs, you can compare the effects of market volatilities on Monopar Therapeutics and Avax Techs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Avax Techs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Avax Techs.
Diversification Opportunities for Monopar Therapeutics and Avax Techs
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Monopar and Avax is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Avax Techs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avax Techs and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Avax Techs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avax Techs has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Avax Techs go up and down completely randomly.
Pair Corralation between Monopar Therapeutics and Avax Techs
Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 6.35 times more return on investment than Avax Techs. However, Monopar Therapeutics is 6.35 times more volatile than Avax Techs. It trades about 0.08 of its potential returns per unit of risk. Avax Techs is currently generating about -0.06 per unit of risk. If you would invest 202.00 in Monopar Therapeutics on September 1, 2024 and sell it today you would earn a total of 2,051 from holding Monopar Therapeutics or generate 1015.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Monopar Therapeutics vs. Avax Techs
Performance |
| Timeline |
| Monopar Therapeutics |
| Avax Techs |
Monopar Therapeutics and Avax Techs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monopar Therapeutics and Avax Techs
The main advantage of trading using opposite Monopar Therapeutics and Avax Techs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Avax Techs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avax Techs will offset losses from the drop in Avax Techs' long position.| Monopar Therapeutics vs. Tff Pharmaceuticals | Monopar Therapeutics vs. Eliem Therapeutics | Monopar Therapeutics vs. Inhibrx | Monopar Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |